Asston Pharmaceuticals Debt to Equity Ratio

Asston Pharmaceuticals Ltd Debt to Equity Ratio

The Asston Pharmaceuticals Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Asston Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Asston Pharmaceuticals Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Asston Pharmaceuticals Ltd (NSE: , BSE: 544445) is currently trading at ₹81, with a market capitalization of ₹662.01M. As a leading company in the Distribution services sector and Medical distributors industry, monitoring the Asston Pharmaceuticals Ltd Debt to Equity Ratio is essential for fundamental analysis.

Asston Pharmaceuticals Ltd Debt to Equity Ratio Current Value

The current Asston Pharmaceuticals Ltd Debt to Equity Ratio stands at 0.66.

The Asston Pharmaceuticals Ltd Debt to Equity Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Asston Pharmaceuticals Ltd Debt to Equity Ratio Historical Trend

The Asston Pharmaceuticals Ltd Debt to Equity Ratio has shown the following historical trend:

• 2024: 0.66
• 2023: 0.95
• 2022: 2.64
• 2021: 3.56

The decline in Asston Pharmaceuticals Ltd Debt to Equity Ratio indicates improving financial efficiency or better earnings growth.

What Asston Pharmaceuticals Ltd Debt to Equity Ratio Indicates for Investors

The Asston Pharmaceuticals Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.

The D/E ratio measures financial leverage and balance sheet strength.

Asston Pharmaceuticals Ltd Debt to Equity Ratio Analysis Summary

The Asston Pharmaceuticals Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Asston Pharmaceuticals Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Asston Pharmaceuticals Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.